{"filing":{"accession_number":"0001213900-26-079616","cik":"0001839285","ticker":"HCTI","company_name":"Healthcare Triangle, Inc.","form":"8-K","filing_date":"2026-07-20","report_date":null,"primary_document":"ea0298570-8k_healthcare.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026079616/ea0298570-8k_healthcare.htm"},"events":[{"id":18783,"run_id":16898,"accession_number":"0001213900-26-079616","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a classic Item 5.07 disclosure reporting the results of Healthcare Triangle's July 17, 2026 annual shareholder meeting. The filing presents voting tallies for nine proposals, including director elections, auditor ratification, stock plan amendments, and critically, approval of multiple dilutive issuances (2.8M shares to SecureKloud, up to 11.9M shares in the Teyame transaction, convertible debentures, and ELOC securities). These shareholder approvals of substantial equity issuances are material to investors assessing dilution and capital structure.","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-07-20","form":"8-K","submitted_at":null,"items":[{"id":17695,"accession_number":"0001213900-26-079616","item_number":"5.07","item_title":"Submission of Matters to a Vote","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Healthcare Triangle's July 17, 2026 annual shareholder meeting. The filing presents voting tallies for nine proposals, including director elections, auditor ratification, stock plan amendments, and critically, approval of multiple dilutive issuances (2.8M shares to SecureKloud, up to 11.9M shares in the Teyame transaction, convertible debentures, and ELOC securities). These shareholder approvals of substantial equity issuances are material to investors assessing dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T20:08:46.697920+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17695,"accession_number":"0001213900-26-079616","item_number":"5.07","item_title":"Submission of Matters to a Vote","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Healthcare Triangle's July 17, 2026 annual shareholder meeting. The filing presents voting tallies for nine proposals, including director elections, auditor ratification, stock plan amendments, and critically, approval of multiple dilutive issuances (2.8M shares to SecureKloud, up to 11.9M shares in the Teyame transaction, convertible debentures, and ELOC securities). These shareholder approvals of substantial equity issuances are material to investors assessing dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T20:08:46.697920+00:00","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-07-20"}]}